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Nutrient-Gene Interactions
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Proteins in HepG2 Hepatocarcinoma Cells1
Rocio Rodriguez-Melendez,* Jacob B. Griffin,* Gautam Sarath,† and Janos Zempleni* **2
*Department of Nutrition and Health Sciences, †U.S. Department of Agriculture-ARS and Department of
Entomology, and **Departments of Biochemistry and Animal Science, University of Nebraska at Lincoln,
Lincoln, NE

KEY WORDS:

●

biotin

●

cell signaling

●

HepG2 cells

●

In mammals, biotin serves as a covalently bound coenzyme
for acetyl-CoA carboxylase, pyruvate carboxylase, propionylCoA carboxylase (PCC),3 and 3-methylcrotonyl-CoA carboxylase (1). These enzymes catalyze essential steps in the metabolism of glucose, amino acids, and fatty acids (1). Biotin
deficiency is associated with decreased carboxylase activities in
humans (2) and other species (3,4). Consistent with the
essential roles of carboxylases in intermediary metabolism,
biotin deficiency may decrease rates of cell proliferation (5,6),
impair immune function (7–9), and derange fetal development
(10 –12).
Biotin also plays an important role in cell signaling, mediating some of the adverse effects of biotin deficiency and
overdose. DNA microarrays have aided in the identification of

human

●

tyrosine kinase

270 and 1803 biotin-dependent genes in human lymphocytes
and hepatocarcinoma (HepG2) cells, respectively (13,14). Effects of biotin on gene expression are mediated by various cell
signals, including the transcription factors nuclear factor
(NF)-B, (15), Sp1 and Sp3 (16), the biotin metabolite biotinyl-AMP (17), and the covalent linkage of biotin to histones (DNA-binding proteins) (18).
The abundance of a given protein is determined not only by
the transcriptional activity of the corresponding gene but also
by post-transcriptional events. We provided evidence that the
expression of some ribosomal proteins and eukaryotic translation initiation factor 5A is greater in biotin-deficient HepG2
cells compared with biotin-sufficient controls (14); theoretically, this may increase the translational activity in biotindeficient cells. Moreover, we provided evidence that supplementation of human cells with pharmacological doses of biotin
impairs the post-translational processing of proteins in the
endoplasmic reticulum (J. B. Griffin and J. Zempleni, unpublished results). These effects of biotin are mediated by decreased expression of sarco/endoplasmic reticulum ATPase3,
diminishing transport of calcium from the cytoplasm into the
endoplasmic reticulum. A low concentration of calcium in the
endoplasmic reticulum impairs protein folding by calcium-
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ABSTRACT Biotin affects the abundance of mRNA coding for ⬃10% of genes expressed in human-derived
hepatocarcinoma (HepG2) cells. Here, we determined whether effects of biotin on gene expression are associated
with changes in the abundance of distinct proteins in cell signaling and structure. HepG2 cells were cultured in
media containing the following concentrations of biotin: 0.025 nmol/L (denoted “deficient”), 0.25 nmol/L (“physiological” ⫽ control), and 10 nmol/L (“pharmacological”) for 10 d before harvesting. The abundance of 1009 proteins
from whole-cell extracts was quantified by using high-throughput immunoblots. The abundance of 44 proteins
changed by at least 25% in biotin-deficient and biotin-supplemented cells compared with physiological controls.
One third of these proteins participate in cell signaling. Specifically, proteins associated with receptor tyrosine
kinase–mediated signaling were identified as targets of biotin; the abundance of these proteins was greater in
biotin-deficient cells than in controls. This was associated with increased DNA-binding activities of the transcription
factors Fos and Jun, and increased expression of a reporter gene driven by activator protein (AP)1-binding
elements in biotin-deficient cells compared with physiological controls. The abundance of selected signaling
proteins was not paralleled by the abundance of mRNA, suggesting that biotin affects expression of these genes
at a post-transcriptional step. Additional clusters of biotin-responsive proteins were identified that play roles in
cytoskeleton homeostasis, nuclear structure and transport, and neuroscience. This study is consistent with the
existence of clusters of biotin-responsive proteins in distinct biological processes, including signaling by Fos/Jun;
the latter might mediate the proinflammatory and antiapoptotic effects of biotin deficiency.
J. Nutr. 135:
1659 –1666, 2005.
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MATERIALS AND METHODS
Cell culture. HepG2 cells were purchased from American Type
Culture Collection. Cells were cultured in the following biotindefined media for 10 d before sample collection (5% CO2 at 37°C in
humidified atmosphere): 0.025 nmol/L of biotin (denoted “deficient”), 0.25 nmol/L of biotin (“physiological”), and 10 nmol/L of
biotin (“pharmacological”). Culture media were replaced with fresh
media every 48 h. Media were prepared using biotin-depleted fetal
bovine serum as described previously (6); biotin concentrations in
media were confirmed by avidin-binding assay (28) with modifications (6). Cultures were trypsinized and split before cells reached
confluence. For the assays described below, cell pellets were collected
at 60 –70% confluence.
Biotin concentrations in media were chosen based on the following lines of reasoning: 1) 0.25 nmol/L of biotin represents the physiological concentration of biotin in plasma from healthy adults (29);
2) 0.025 nmol/L of biotin is ⬎2 SD below the mean physiological
concentration in normal plasma (29); thus 0.025 nmol/L equals a
deficient concentration of biotin; 3) ingestion of a typical biotin
supplement providing 25 times the Adequate Intake of biotin for
adults (30) is associated with plasma concentrations of ⬃10 nmol/L
of biotin in healthy adults (31); thus, this concentration represents a
pharmacological concentration of biotin in plasma. Culturing HepG2
cells in biotin-defined media for 10 d provides sufficient time in
which to achieve new intracellular steady-state concentrations of
biotin, as judged by activities of biotin-dependent PCC and by
biotinylation of carboxylases (6,32).
Biotin-dependent carboxylases. Biotin-dependent carboxylases
are reliable markers for cellular biotin (1). Biotinylated carboxylases
in cell extracts were resolved by PAGE and were probed using
streptavidin peroxidase (6); signal intensities were quantified using
gel densitometry (16). The activities of PCC in cell extracts were
quantified as described previously (6).
Immunoblotting. For preparation of cell extracts, adherent cells
in 75-cm2 tissue culture flasks were rinsed with PBS, and the saline
was discarded. Boiling lysis buffer (3 mL/flask; 10 mmol/L Tris, pH
7.4, 1 mmol/L sodium vanadate, 35 mmol/L lauryl sulfate) was added;
the solution was swirled to ensure rapid protein denaturation. The
cell lysate was collected with a cell scraper, and the sample was
heated in a water bath at 100°C for 30 s. The cellular DNA was
sheared by passing the cell lysate 10 times through a 25-gauge needle.
Samples were frozen in liquid nitrogen and stored at ⫺80° for 2 d
before analyses.
High-throughput immunoblotting (“PowerBlot”) of cell lysates
was conducted using a commercial facility (BD Biosciences Pharmingen) as described (33). Briefly, proteins (200 g/gel) were resolved
using 2-D electrophoresis, followed by electroblotting onto polyvinylidene fluoride membranes. Proteins on membranes were probed

using an array of antibodies to 1009 human proteins; the identities of
these proteins are available on the facility’s website (33). Proteins
were quantified by using appropriate fluorophore-labeled secondary
antibodies and the Odyssey Infrared Imaging System (LI-COR).
Immunoblots were run in triplicate. Changes in protein abundance in
response to biotin were ranked by order of confidence in data quality,
using a scale from 1 to 10 (10 ⫽ highest level of confidence); ranking
was based primarily on signal quality, consistency of data within
triplicates, and magnitude of the observed change (treatment vs.
physiological control) (33). Here, only data from confidence levels
7–10 were included in analysis: level 10 ⫽ ratio of the signal “treatment to control” (or “control to treatment”) ⬎ 2, good quality
signals, pass visual inspection; level 9 ⫽ signal ratio 1.5–1.9, good
quality signals, pass visual inspection; level 8 ⫽ signal ratio 2, low
signals, pass visual inspection; and level 7 ⫽ signal ratio 1.25–1.5,
good quality signals, pass visual inspection.
The abundance of selected proteins in cell extracts was confirmed
individually using 1-dimensional gel electrophoresis as described
(34); antibodies were purchased from BD Biosciences Pharmingen,
As a control, we quantified histone H4 in nuclear extracts (35);
anti-human histone H4 antibody was purchased from Santa Cruz
Biotechnology.
RT-PCR. The expression of genes encoding SAM68, AF6,
GRB2, and histone H4 (control) was quantified by RT-PCR as
described (36). Test genes and control gene were analyzed simultaneously in separate tubes in the same thermocyler. The following
customized primers were used for PCR (Integrated DNA Technologies):1) 5⬘-GTC CCA CTA TGA ATA TCT C-3⬘ and 5⬘-AGC
TGC CCT ATT TAG TAG A-3⬘ for human AF6 (GenBank accession number U02478); 2) 5⬘-CTG TAT TGG GAA AGG GCT
CA-3⬘ and 5⬘- CCC CTT GAC TCT GGC TGT AA-3⬘ for human
SAM68 (GenBank accession number NM_130405); 3) 5⬘-GAG
CTT AAT GGA AAA GAC G-3⬘ and 5⬘-TTG ACT CTT AGA
CGT TCC G-3⬘ for human GRB2 (GenBank accession number
NM_002086); and 4) 5⬘-ATG TCT GGT AGA GGC AAA GGT
GGT AAA-3⬘ and 5⬘-TCA GCC ACC AAA GCC GTA CAG
AGT GCG-3⬘ for human histone H4 (GenBank accession number
M60749). cDNA was quantified by gel densitometry using the Kodak
EDAS 290 Documentation and Analysis System; only values from
within the exponential phase of PCR amplification were considered
for data analysis. The abundance of mRNA encoding SAM68, AF6,
and GRB2 was normalized by the abundance of mRNA encoding
histone H4.
Electrophoretic mobility shift assays (EMSA). The data presented below are consistent with effects of biotin on signaling by
receptor tyrosine kinases. Signaling by receptor tyrosine kinases converges on transcription factors Fos and Jun, which have affinity for
activator protein (AP)1 elements in regulatory regions of genes (37).
EMSA were used to determine whether putative effects of biotin on
tyrosine kinase signaling affect the AP1-binding activity in HepG2
cell nuclei. Nuclear extracts were prepared as described previously
(16). AP1-binding factors in nuclear extracts were probed by EMSA
(15), using a 32P-labeled double-stranded oligonucleotide probe with
an AP1 consensus site: 5⬘-CGC TTG ATG AGT CAG CCG
GAA-3⬘ and 5⬘-TTC CGG CTG ACT CAT CAA GCG-3⬘ (Promega). The nuclear protein-binding activity to ets1 sites (control)
was quantified using the following oligonucleotide probes: 5⬘-GTA
TTG TTG TTC CTC CAT TTC TAG AAT ATT-3⬘ and 5⬘-AAT
ATT CTA GAA ATG GAG GAA CAA CAA TAC-3⬘ (IDTDNA
Technologies) (38). Additional controls were prepared by omitting
nuclear extracts from incubation mixtures, and by incubating nuclear
extracts with radiolabeled probe in the presence of a molar excess of
unlabeled probe. In some cases, transcription factor-oligonucleotidecomplexes were supershifted by using polyclonal rabbit IgG antihuman antibody to c-Jun (Santa Cruz Biotechnology). These samples
were prepared by incubating 5 g of nuclear protein with 2 g of
antibody to c-Jun for 60 min at 4°C before adding oligonucleotide
probes. Note that incubation of nuclear proteins with antibodies 1)
may prevent the formation of transcription factor-oligonucleotide
complexes (if antibodies block oligonucleotide-binding sites of transcription factors); or 2) may decrease the electrophoretic mobility of
the transcription factor-oligonucleotide-complex (if antibodies bind
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dependent calnexin (19,20), BiP (21), and protein disulfide
isomerase (21). This is associated with high proteolytic activity (22), increased expression of chaperones that mediate
protein folding (23,24), and low overall translational activity
(25).
In the present study, we tested the hypothesis that biotin
affects the abundance of distinct proteins in HepG2 cells.
Specifically, we focused on signaling proteins, given that biotin-dependent synthesis of these proteins may have important effects on the transcriptional activity of numerous genes
(15,16,26). For protein analysis, we applied a novel proteomics
technique that permits quantification of ⬃1009 proteins in
one single run. HepG2 cells were selected as a cell model based
on the following lines of reasoning: 1) HepG2 cells express a
variety of proteins in large quantities (27); 2) the effects of
biotin on mRNA abundance have been quantified in previous
DNA microarray studies in HepG2 cells (14); and 3) the
effects of biotin concentrations in culture media on biotin
homeostasis in HepG2 cells have been well characterized
(14,17).

BIOTIN-DEPENDENT PROTEIN CLUSTERS
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RESULTS
Biotin-dependent carboxylases. Biotinylation of carboxylases in HepG2 cells depended on the biotin concentration in
the culture media. If cells were cultured in biotin-deficient
medium, biotinylated pyruvate carboxylase, PCC, and 3-methylcrotonyl-CoA carboxylase were barely detectable in cell
extracts, using streptavidin peroxidase as a probe (Fig. 1A).
Note that the biotin-containing ␣-chains of PCC (molecular
mass ⫽ 80 kDa) and 3-methylcrotonyl-CoA carboxylase (molecular mass ⫽ 83 kDa) migrate as 1 single band on the
polyacrylamide gels used here. The abundance of holocarboxylases was similar in cells cultured in media containing deficient
and physiological concentrations of biotin, as judged by gel
densitometric analysis of streptavidin blots (Fig. 1B). In contrast, holocarboxylases were 6.3– 62 times more abundant in
biotin-supplemented cells compared with cells cultured in
media containing deficient or physiological concentrations of
biotin. Acetyl-CoA carboxylase was barely detectable in cell
extracts (Fig. 1A), consistent with previous studies in human
cell cultures (6,40); hence, acetyl-CoA carboxylase was not
quantified by gel densitometry. PCC activities in HepG2 cells
depended on the concentration of biotin in culture media
[units ⫽ pmol bicarbonate fixed/(min 䡠 mg protein)]: biotindeficient medium ⫽ 21 ⫾ 2.5; physiological medium ⫽ 45
⫾ 3.2; and pharmacological medium ⫽ 266 ⫾ 22 (P ⬍ 0.01
among all treatment groups; n ⫽ 3 separate experiments).
These findings are consistent with the hypothesis that biotin
concentrations in culture media affect intracellular biotin concentrations.
Immunoblot analysis. Biotin affected the abundance of 44
proteins in HepG2 cells, as judged by high-throughput immunoblot analysis; this equals 4.4% of the proteins tested. The
abundance of 12 proteins increased by ⬎25% in response to
biotin deficiency compared with physiological controls; the
abundance of 17 proteins decreased by ⬎25% in response to

FIGURE 1 Biotin concentrations in culture media affect the abundance of holocarboxylases in HepG2 cells. Cells were cultured in media
containing deficient (0.025 nmol/L), physiological (0.25 nmol/L), and
pharmacological (10 nmol/L) concentrations of biotin for 10 d. Panel A:
Representative Western blot depicting acetyl-CoA carboxylase (ACC),
pyruvate carboxylase (PC), ␣-chain of propionyl-CoA carboxylase
(PCC), and ␣-chain of 3-methylcrotonyl-CoA carboxylase (MCC). Panel
B: Gel densitometric analysis of Western blots. Values are means ⫾ SD
(n ⫽ 3 separate experiments). aDifferent from the abundance of the
same carboxylase in cells cultured in physiological medium (P ⬍ 0.01).

biotin deficiency (see Appendix). The abundance of 3 proteins
increased by ⬎25% in response to pharmacological concentrations of biotin in culture medium compared with physiological controls; the abundance of 16 proteins decreased by
⬎25% in response to biotin supplementation (see Appendix).
The following proteins exhibited the largest increase in biotindeficient cells compared with physiological controls (see the
Appendix for Swiss Prot ID numbers): GRB2 (410% increase),
SAM68 (324% increase), LRII/SorLA/gp250 (169% increase), and A-RAF (134% increase). The following genes
exhibited the largest decrease in biotin-deficient cells compared with physiological controls: AF6 (not detectable in
biotin-deficient cells), GGA2 (69% decrease), E-cadherin
(53% decrease), and EBP50 (51% decrease). The following
proteins exhibited the largest increase in biotin-supplemented
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to transcription factors without blocking their oligonucleotide-binding sites).
Reporter-gene constructs. The following constructs were used to
determine whether the biotin concentration in culture media affects
the transcriptional activity of AP1-dependent genes: 1) a construct of
the luciferase reporter gene driven by a basic promoter element
(TATA box) and 7 AP1 enhancer elements (denoted “AP1-Luc”)
was purchased from Stratagene; 2) a promoter-free plasmid containing the luciferase gene (“pGL3-Basic”; Promega,) was used to quantify
baseline luciferase expression in cells; and 3) a construct of the SV40
promoter and enhancer linked to the ␤-galactosidase reporter gene
(“pSV-␤-Galactosidase”; Promega) was used to quantify transfection
efficiency.
Cells were transfected with reporter-gene constructs by using
FuGene 6 (Roche) according to the manufacturer’s instructions; 48 h
after transfection, luciferase and ␤-galactosidase activities were quantified in cell lysates as described (32). Luciferase activities were
normalized for transfection efficiency by using ␤-galactosidase activities. Data are expressed as ratios of luciferase activities in cells
transfected with AP1-Luc to activities in cells transfected with pGL3Basic.
Statistical analysis. Homogeneity of variances among groups
was tested using Bartlett’s test (39). If variances were heterogeneous,
the data were log-transformed before further statistical analysis. Significance of differences among groups was tested by one-way
ANOVA. Fisher’s Protected Least Significant Difference procedure
was used for post-hoc testing (39). StatView 5.0.1 (SAS Institute)
was used to perform all calculations. Differences were considered
significant if P ⬍ 0.05. Data are expressed as means ⫾ SD or as
median (and 33th, 66th percentile); replicates represent data collected from assays of separate cultures as opposed to assaying the same
sample from one culture multiple times.
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FIGURE 2 The relative abundance of proteins from high-throughput immunoblot analysis was confirmed using 1-dimensional gel electrophoresis. HepG2 cells were cultured in media containing deficient
(0.025 nmol/L), physiological (0.25 nmol/L), and pharmacological (10
nmol/L) concentrations of biotin for 10 d. High-throughput immunoblot
analysis suggested that the abundance of the following proteins increased in response to biotin deficiency: SAM68 (SwissProt ID:
Q07666); GRB2 (SwissProt ID: P29354); A-RAF (SwissProt ID: P04627).
Here, these findings were validated by Western blot analysis using a
1-dimensional gel electrophoresis system.

TABLE 1
Biotin concentrations in culture media affect the abundance
of protein clusters in HepG2 cells
Treatment (biotin in culture
medium)1
Protein cluster2

Confidence
level3

Deficient

Pharmacological

Protein abundance
(compared with physiological
controls)1
Cell signaling
GRB2
Sam68
AF6
Annexin II
A-RAF
TNIK
CDC42GAP
PSD-95
Tpl-2
GAP1m
IRS-1
c-Cbl
Nucleus and nuclear
transport
Ku70
Smad4/DPC4
ICBP90
No55
RanBP3
Stat2
hSlu7
FIP-2
CTCF
TIP49b
Cytoskeleton
E-Cadherin
EBP50
Gelsolin
EB1
CLP-36
L-caldesmon
Neuroscience
Amphiphysin
Nogo A
b1-Calcium
channel
Nurr
Syntaxin 4
PCMT-I/II
Cell biology
mEPHX
ATP synthase b
GGA2
BPntase
LR11/SorLA
Others
E-Cadherin
eIF-4F
LRP
FKBP65
CDC27

10
10
10
10
9
9
8
8
8
8
7
7

Increase
Increase
Decrease

9
8
7
7
7
7
7
7
7
7

Decrease

9
9
8
7
7
7

Decrease
Decrease

8
8
8

Decrease
Decrease
Decrease

7
7
7

Decrease
Increase
Increase

Decrease
Increase
Decrease
Decrease
Decrease

Decrease
Decrease4
Decrease
Decrease4
Decrease

Increase

Decrease
Decrease
Increase
Decrease
Increase
Decrease
Decrease
Increase
Decrease

Increase
Increase
Decrease
Decrease

10
9
9
7
9

Increase

9
7
7
7
7

Decrease
Increase
Increase
Decrease
Increase

Decrease4
Decrease4
Decrease4

Decrease
Decrease
Decrease
Decrease

1
HepG2 cells were cultured in media containing 0.025 nmol/L biotin
(“deficient”), 0.25 nmol/L biotin (“physiological” ⫽ control), and 10
nmol/L biotin (“pharmacological”) for 10 d.
2
SwissProt IDs of proteins are provided in the Appendix.
3
The “Confidence level” is a measure for data quality on a scale
from 1 to 10 (10 being the highest; see Materials and Methods for
details).
4
The abundance of this protein decreased in response to both
deficient and pharmacological concentrations of biotin compared with
physiological controls.
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cells compared with physiological controls: gelsolin (950%
increase), CTCF (76% increase), and No55 (67% increase).
The following genes exhibited the largest decrease in biotinsupplemented cells compared with physiological controls: annexin II (83% decrease), mEPHX (61% decrease), ATP synthase b (59% decrease), and TNIK (55% decrease).
Comparative analysis of protein abundance by highthroughput 2-D-immunoblots and 1-dimensional gel electrophoresis produced similar trends. Here, we selected 3 proteins
that were increased in response to biotin deficiency, as judged
by high-throughput immunoblotting (see above): SAM68,
GRB2, and RAF. When these proteins were assayed using
1-dimensional gel electrophoresis and gel densitometry, the
abundance was greater in biotin-deficient cells compared with
the other treatment groups (Fig. 2): SAM68 ⫽ 87% increase;
GRB2 ⫽ 32% increase; and RAF ⫽ 12% increase. The abundance of histone H4 (loading control) was not affected by
biotin (data not shown). These data are consistent with the
notion that data obtained by high-throughput 2-D-immunoblots are precise.
Protein clusters. Biotin-responsive proteins were not randomly distributed in the genome. Rather, biotin-responsive
proteins clustered in classes of distinct molecular and biological functions (Table 1). The quantitatively most important
cluster comprised proteins that play roles in cell signaling. Of
a total of 44 biotin-responsive proteins, 12 were associated
with this cluster; 5 of these biotin-responsive signaling proteins are linked to receptor tyrosine kinase pathways as described below. Biotin also affected the abundance of protein
clusters that play roles in nuclear structure and transport (10
proteins), formation of the cytoskeleton (6 proteins), neuroscience (6 proteins), and cell biology (5 proteins); proteins
with other molecular and biological functions accounted for

BIOTIN-DEPENDENT PROTEIN CLUSTERS

both biotin-deficient and biotin-supplemented cells compared
with physiological controls. Phosphorylated MEK catalyze
phosphorylation and, hence, activation of MAPK such as
extracellular signal-related kinase (ERK)1 and ERK2. Phosphorylated ERK mediate phosphorylation of Fos and Jun,
enhancing the transcriptional activity of genes driven by AP1
and NF-B binding motifs.
EMSA. The AP1-binding activity was greater in nuclear
extracts from biotin-deficient cells than in extracts from cells
cultured in physiological or pharmacological media (Fig. 4,
lanes 1–3); no band was observed in the absence of nuclear
extract (negative control, lane 4). The following findings
suggest that the binding of transcription factors to AP1 sites
was a specific event: 1) band intensities decreased substantially
if nuclear extracts were incubated with radiolabeled oligonucleotides in the presence of a 50-fold molar excess of unlabeled
oligonucleotides (Fig. 4, lanes 5–7); and 2) bands were supershifted by incubation with antibody to c-Jun before conducting EMSA (lanes 8 –10). Finally, biotin deficiency was not
associated with increased protein-binding activity to ets1 sites
(Fig. 4A, lanes 11–13). Rather, biotin deficiency was associated with a moderate decrease in protein-binding activity to
ets1 sites. This is consistent with the hypothesis that biotin
supplementation specifically increased the nuclear activity of
AP1-binding transcription factors as opposed to causing a
global increase in the nuclear translocation of various transcription factors.
Transcriptional activities of AP1-dependent reporter
genes. The transcriptional activity (luciferase activity) of a
reporter gene (AP1-Luc) driven by 5 AP1 elements was 23–
45% greater in biotin-deficient cells than in cells cultured in
media containing physiological or pharmacological concentrations of biotin (units ⫽ ratio of AP1-Luc to pGL3-basic):
0.025 nmol/L biotin ⫽ 1.6 ⫾ 0.3 U; 0.25 nmol/L biotin ⫽ 1.1
⫾ 0.2 U; and 10 nmol/L biotin ⫽ 1.3 ⫾ 0.04 U (P ⬍ 0.05 for
0.025 nmol/L biotin vs. 0.25 nmol/L; n ⫽ 3).

FIGURE 3 Flow chart of receptor
tyrosine kinase-mediated cell signaling
in human cells. Binding of ligand to
receptor tyrosine kinases causes
dimerization and autophosphorylation.
Signaling proteins such as GRB2 and
SOS associate with phosphorylated
tyrosine receptor kinases, triggering
signaling cascades involving kinases
such as RAS, RAF, MEK, and MAPK.
Ultimately, the transcription factors
Fos and Jun are phosphorylated and
translocate to the nucleus, where they
activate AP1-dependent genes.
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the remainder of the biotin-responsive proteins (5 proteins).
Five biotin-responsive proteins decreased in both biotin-deficient and biotin-supplemented cells compared with physiological controls (Table 1; see Discussion).
Signaling by receptor tyrosine kinase pathways. Biotin
deficiency was associated with increased abundance of proteins
that play roles in receptor tyrosine kinase signaling. In this
section, we provide both data on protein abundance and a
brief review of receptor tyrosine kinase signaling for clarity.
Receptor tyrosine kinases span the cell membrane in mammalian cells (Fig. 3) (37). Various ligands have affinity for the
ligand-binding domain located in the extracellular domain of
receptor tyrosine kinases; ligands include platelet-derived
growth factor, insulin, thrombin, and various other compounds. Binding of ligands causes dimerization of receptors
and activation of the tyrosine kinase domain in the cytoplasmic domain; this is associated with autophosphorylation of the
C-terminus of the receptor. The phosphorylated receptor has
affinity for GRB2 (and perhaps its homolog SAM68) and
SOS. In the present study, the abundance [median (33rd, 66th
percentile)] of GRB2 and SAM68 was 410% (250%, 1249%)
and 324% (247%, 404%) greater, respectively, in biotin-deficient HepG2 cells compared with physiological controls.
Binding of the G protein SOS to the phosphorylated receptor
tyrosine kinase triggers a substitution of GTP for GDP in the
serine/threonine kinase RAS, mediating catalytic activity. In
the present study, the abundance of the Ras-interacting protein AF6 decreased to nondetectable levels in response to
biotin deficiency, presumably further enhancing Ras activity
(41,42). Ras mediates phosphorylation of the serine/threonine
kinase RAF1, causing activation of RAF1. In the present
study, the abundance of RAF1 was 134% (101%, 145%)
greater in biotin-deficient cells than in physiological controls.
RAF1 catalyzes phosphorylation and, hence, activation of
mitogen-activated protein kinases (MAPK) kinases (MAPKK
or MEK). In the present study, the abundance of the MAP
kinase kinase kinase Tpl2 decreased to nondetectable levels in
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Gene expression analysis. Biotin-dependent changes in
protein abundance appeared independent of transcription. As
models, we selected 3 proteins that were more abundant in
biotin-deficient HepG2 cells than in physiological controls:
SAM68 (324% increase of protein), AF6 (not detectable in
physiological control), and GRB2 (410% increase of protein).
The following data were obtained for the abundance of
SAM68 mRNA (units ⫽ % of mRNA in physiological controls, 0.25 nmol/L): 0.025 nmol/L biotin ⫽ 98 ⫾ 14%; 0.25
nmol/L biotin ⫽ 100 ⫾ 30%; and 10 nmol/L biotin ⫽ 90 ⫾ 53
U (P ⬎ 0.05; n ⫽ 5). The following data were obtained for the
abundance of AF6 mRNA (units ⫽ % of mRNA in physiological controls, 0.25 nmol/L): 0.025 nmol/L biotin ⫽ 92
⫾ 36%; 0.25 nmol/L biotin ⫽ 100 ⫾ 46%; and 10 nmol/L
biotin ⫽ 69 ⫾ 54% (P ⬎ 0.05; n ⫽ 5). The following data
were obtained for the abundance of GRB2 mRNA (units ⫽ %
of mRNA in physiological controls, 0.25 nmol/L): 0.025
nmol/L biotin ⫽ 114 ⫾ 35%; 0.25 nmol/L biotin ⫽ 100
⫾ 22%; and 10 nmol/L biotin ⫽ 127 ⫾ 40% (P ⬎ 0.05; n
⫽ 4).
DISCUSSION
The present study provides evidence 1) that biotin affects
the abundance of proteins in HepG2 cells; 2) that these
biotin-responsive proteins can be grouped into distinct clusters
based on biological function; 3) that about one-third of these
biotin-responsive proteins are associated with cell signaling
pathways; 4) that biotin deficiency causes increased abundance of proteins that play roles in signaling by receptor
tyrosine kinases; 5) that activation of receptor tyrosine kinase
pathways is associated with nuclear translocation of AP1binding proteins and transcriptional activation of AP1-depen-
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FIGURE 4
Nuclear translocation of AP1-binding proteins increases in response to biotin deficiency. HepG2 cells were cultured in
media containing deficient (“D,” 0.025 nmol/L), physiological (“P,” 0.25
nmol/L), and pharmacological (“H” ⫽ high, 10 nmol/L) concentrations
of biotin for 10 d. Transcription factors in nuclear extracts were probed
by EMSA, using the following oligonucleotide probes and conditions:
lanes 1–3 ⫽ oligonucleotide containing an AP1 consensus site; lane 4
⫽ AP1 oligonucleotide in the absence of nuclear extract; lanes 5–7
⫽ 50-fold molar excess of unlabeled compared to radiolabeled AP1
oligonucleotide; lanes 8 –10 ⫽ AP1 oligonucleotide, supershifted by
using an antibody to c-Jun; lanes 11–13 ⫽ oligonucleotide containing
an ets1 site. Abbreviations: NE ⫽ no extract; Ab ⫽ antibody (supershift
experiments); cold ⫽ excess of cold (unlabeled) probe.

dent genes in biotin-deficient cells; and 6) that biotin affects
gene expression at both the transcriptional level (e.g., AP1mediated transcriptional activation) and the post-transcriptional level (e.g., translation of SAM68, AF6, and GRB2) in
HepG2 cells.
The findings reported here are consistent with the hypothesis that biotin affects gene expression by modulating the
nuclear translocation of Fos and Jun. Fos/Jun heterodimers
bind AP1 sites with 30 times greater affinity than Jun homodimers, whereas Fos homodimers do not have AP1-binding
affinity (43). In the present study, incubation of samples with
an antibody to Jun caused a supershift in EMSA, suggesting
that Jun participates in biotin-dependent cell signaling. We
cannot formally exclude the possibility that Fos and other
AP1-binding proteins (e.g., Fras ⫽ Fos-related antigens) account for some of the increased AP1-binding activity in biotin-deficient cells. Note that biotinyl-AMP, Sp1 and Sp3,
and NF-B also mediate effects of biotin on gene expression
(15–17). Future studies are likely to identify additional biotindependent signaling pathways involving the proteins listed in
the appendix of this article.
What are the biological consequences of activating AP1dependent genes in response to biotin deficiency? We speculate that Fos and Jun mediate increased expression of the
biotin transporters SMVT and MCT1 in response to biotin
deficiency (6,40). The regulatory region of the human SMVT
gene contains 4 AP1 sites and 1 AP1-like site (44), whereas
the regulatory region of the human MCT1 gene contains 2
AP1 sites (45). In addition to its putative effects on biotin
transporter expression, nuclear translocation of Fos and Jun
might enhance stress resistance of biotin-deficient cells (46 –
48) in analogy to effects of biotin on NF-B (15). We speculate that the increased nuclear abundance of both Fos/Jun
and NF-B observed in biotin-deficient cells might contribute
to the proinflammatory and antiapoptotic effects of biotin
deficiency.
This study provides evidence for the feasibility of identifying nutrient-responsive proteins by using high-throughput immunoblot screening. The level of confidence in this approach
is high, based on the following lines of evidence. First, observations from high-throughput immunoblot screening were
confirmed by using 1-dimensional gel electrophoresis. Second,
distinct proteins from a given signaling pathway (receptor
kinase signaling) showed synergistic changes in response to
biotin deficiency. Third, changes in the abundance of signaling proteins were paralleled by changes in downstream events,
i.e., transcriptional activity of target genes. The application of
high-throughput immunoblot screens to various test situations
is likely to result in the identification of novel nutrientdependent pathways.
At first glance, the number of biotin-responsive proteins
identified here may seem small (44 proteins). However, on a
relative basis, these 44 proteins represent 4.4% of the proteins
screened for, which is moderately less than the percentage of
biotin-dependent transcripts identified in the same cell line:
1803 of 14,000 tested genes (⫽13%) (14). Please note that not
all the proteins included in our high-throughput immunoblot
screening are actually expressed in liver cells. Hence, the true
percentage of biotin-dependent proteins is larger than the
number provided above. In the present study, we applied very
stringent selection criteria when screening for biotin-responsive proteins (see Materials and Methods). Using less stringent
criteria would have resulted in a much larger number of
biotin-responsive proteins (data not shown). Finally, liver cells
also express proteins that were not included in this high-
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8. Báez-Saldaña, A., Dı́az, G., Espinoza, B. & Ortega, E. (1998) Biotin
deficiency induces changes in subpopulations of spleen lymphocytes in mice.
Am. J. Clin. Nutr. 67: 431– 437.
9. Petrelli, F., Moretti, P. & Campanati, G. (1981) Studies on the relationships between biotin and the behaviour of B and T lymphocytes in the guinea pig.
Experientia 37: 1204 –1206.
10. Watanabe, T. (1983) Teratogenic effects of biotin deficiency in mice. J.
Nutr. 113: 574 –581.
11. Watanabe, T., Dakshinamurti, K. & Persaud, T.V.N. (1995) Biotin influences palatal development of mouse embryos in organ culture. J. Nutr. 125:
2114 –2121.
12. Zempleni, J. & Mock, D. M. (2000) Marginal biotin deficiency is teratogenic. Proc. Soc. Exp. Biol. Med. 223: 14 –21.
13. Wiedmann, S., Rodriguez-Melendez, R., Ortega-Cuellar, D. & Zempleni,
J. (2004) Clusters of biotin-responsive genes in human peripheral blood
mononuclear cells. J. Nutr. Biochem. 15: 433– 439.
14. Rodriguez-Melendez, R., Griffin, J. B. & Zempleni, J. (2005) The expression of genes encoding ribosomal subunits and eukaryotic translation initiation factor 5A depends on biotin and bisnorbiotin in HepG2 cells. J. Nutr. Biochem. (in press).
15. Rodriguez-Melendez, R., Schwab, L. D. & Zempleni, J. (2004) Jurkat
cells respond to biotin deficiency with increased nuclear translocation of NF-B,
mediating cell survival. Int. J. Vitam. Nutr. Res. 74: 209 –216.
16. Griffin, J. B., Rodriguez-Melendez, R. & Zempleni, J. (2003) The nuclear abundance of transcription factors Sp1 and Sp3 depends on biotin in Jurkat
cells. J. Nutr. 133: 3409 –3415.
17. Solorzano-Vargas, R. S., Pacheco-Alvarez, D. & Leon-Del-Rio, A. (2002)
Holocarboxylase synthetase is an obligate participant in biotin-mediated regula-

tion of its own expression and of biotin-dependent carboxylases mRNA levels in
human cells. Proc. Natl. Acad. Sci. U.S.A. 99: 5325–5330.
18. Zempleni, J. (2005) Uptake, localization, and noncarboxylase roles of
biotin. Annu. Rev. Nutr. (in press).
19. Bergeron, J.J.M., Brenner, M. B., Thomas, D. Y. & Williams, D. B. (1994)
Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends
Biochem. Sci. 19: 124 –128.
20. Hebert, D. N., Foellmer, B. & Helenius, A. (1995) Glucose trimming and
reglycosylation determine glycoprotein association with calnexin in the endoplasmic reticulum. Cell 81: 425– 433.
21. Macher, D.R.J. & Koch, G.L.E. (1988) Identification of a set of calciumbinding proteins in reticuloplasm, the luminal content of the endoplasmic reticulum. J. Cell Sci. 91: 61–70.
22. Pahl, H. L. (1999) Signal transduction from the endoplasmic reticulum
to the cell nucleus. Physiol. Rev. 79: 683–700.
23. Yoshida, H., Matsui, T., Yamamoto, A., Okada, T. & Mori, K. (2001)
XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to
produce a highly active transcription factor. Cell 107: 881– 891.
24. Rao, R. V., Peel, A., Logviniva, A., Rio, G. D., Hermel, E., Yokota, T.,
Goldsmith, P. C., Ellerby, L. M., Ellerby, H. M. & Bredesen, D. E. (2002) Coupling endoplasmic reticulum stress to the cell death program: role of the ER
chaperone GRP78. FEBS Lett. 514: 122–128.
25. Sidrauski, C., Brickner, J. H. & Walter, P. (2002) The unfolded protein
response. In: Protein Targeting, Transport & Translocation (Dalbey, R. E. & von
Heijne, G., eds.). Academic Press, San Diego, CA.
26. Rodriguez-Melendez, R., Griffin, J. B. & Zempleni, J. (2004) Biotin
supplementation increases expression of the cytochrome P450 1B1 gene in
Jurkat cells, increasing the occurrence of single-stranded DNA breaks. J. Nutr.
134: 2222–2228.
27. American Type Culture Collection (2003) www.atcc.org [accessed
1/30/2003].
28. Mock, D. M. (1997) Determinations of biotin in biological fluids. Methods Enzymol. 279: 265–275.
29. Mock, D. M., Lankford, G. L. & Mock, N. I. (1995) Biotin accounts for
only half of the total avidin-binding substances in human serum. J. Nutr. 125:
941–946.
30. National Research Council (1998) Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin,
and Choline (Institute of Medicine Food and Nutrition Board). National Academy
Press, Washington, DC.
31. Zempleni, J., Helm, R. M. & Mock, D. M. (2001) In vivo biotin supplementation at a pharmacologic dose decreases proliferation rates of human peripheral blood mononuclear cells and cytokine release. J. Nutr. 131: 1479 –1484.
32. Rodriguez-Melendez, R., Camporeale, G., Griffin, J. B. & Zempleni, J.
(2003) Interleukin-2 receptor ␥-dependent endocytosis depends on biotin in
Jurkat cells. Am. J. Physiol. 284: C415–C421.
33. Pharmingen (2003) BD PowerBlot: The Power of Proteomics. http://
bioinfo.clontech.com/powerblot/ [accessed 7/26/2004].
34. Griffin, J. B., Stanley, J. S. & Zempleni, J. (2002) Synthesis of a rabbit
polyclonal antibody to the human sodium-dependent multivitamin transporter.
Int. J. Vitam. Nutr. Res. 72: 195–198.
35. Camporeale, G., Shubert, E. E., Sarath, G., Cerny, R. & Zempleni, J.
(2004) K8 and K12 are biotinylated in human histone H4. Eur. J. Biochem. 271:
2257–2263.
36. Zempleni, J., Stanley, J. S. & Mock, D. M. (2001) Proliferation of
peripheral blood mononuclear cells causes increased expression of the sodiumdependent multivitamin transporter gene and increased uptake of pantothenic
acid. J. Nutr. Biochem. 12: 465– 473.
37. Hesketh, R. (1997) The Oncogene and Tumour Suppressor Gene
FactsBook. Academic Press Harcourt Brace and Company, London, UK.
38. Ohbo, K., Takasawa, N., Ishii, N., Tanaka, N., Nakamura, M. & Sugamura,
K. (1995) Functional analysis of the human interleukin-2 receptor ␥ chain
promoter. J. Biol. Chem. 270: 7479 –7486.
39. SAS Institute Inc. (1999) StatView Reference. SAS Institute, Cary, NC.
40. Crisp, S.E.R.H., Camporeale, G., White, B. R., Toombs, C. F., Griffin,
J. B., Said, H. M. & Zempleni, J. (2004) Biotin supply affects rates of cell
proliferation, biotinylation of carboxylases and histones, and expression of the
gene encoding the sodium-dependent multivitamin transporter in JAr choriocarcinoma cells. Eur. J. Nutr. 43: 23–31.
41. Yamamoto, T., Harada, N., Kawano, Y., Taya, S. & Kaibuchi, K. (1999)
In vivo interaction of AF-6 with activated Ras and ZO-1. Biochem. Biophys. Res.
Commun. 259: 103–107.
42. Linnemann, T., Geyer, M., Jaitner, B. K., Block, C., Kalbitzer, H. R.,
Wittinghofer, A. & Herrmann, C. (1999) Thermodynamic and kinetic characterization of the interaction between the Ras binding domain of AF6 and members
of the Ras subfamily. J. Biol. Chem. 274: 13556 –13562.
43. Latchman, D. S. (1998) Eukaryotic Transcription Factors. Academic
Press, San Diego, CA.
44. Dey, S., Subramanian, V. S., Chatterjee, N. S., Rubin, S. A. & Said, H. M.
(2002) Characterization of the 5⬘ regulatory region of the human sodium-dependent multivitamin transporter, hSMVT. Biochim. Biophys. Acta 1574: 187–192.
45. Hadjiagapiou, C., Borthakur, A., Dahdal, R. Y., Gill, R. K., Malakooti, J.,
Ramaswamy, K. & Dudeja, P. K. (2005) Role of USF1 and USF2 as potential
repressor proteins for human intestinal monocarboxylate transporter 1 (MCT1)
promoter. Am. J. Physiol. (in press).
46. Inoue, H., Tateno, M., Fujimura-Kamada, K., Takaesu, G., Adachi-

Downloaded from jn.nutrition.org at Univ of NE-LincolnLibraries on August 29, 2007

throughput screen. Hence, it is likely that some biotin-responsive proteins escaped detection in the studies presented here.
In the present study, the abundance of SAM68, AF6, and
GRB2 increased in response to biotin deficiency; this increase
was not paralleled by the abundance of mRNA encoding these
proteins. On the basis of these observations, we concluded that
biotin deficiency enhances the expression of SAM68, AF6,
and GRB2 at a post-transcriptional step. Note that we cannot
formally exclude effects of biotin deficiency on the transcriptional activity of genes coding for SAM68, AF6, and GRB2.
For example, alternative splicing of RNA, cell type, and life
cycle may considerably affect mRNA abundance (49). These
variables were not considered in the present study.
A limitation not specifically addressed in the study presented here is the following. The abundance of some proteins
decreased in both biotin-deficient and biotin-supplemented
cells compared with physiological controls. We speculate that
any nonphysiological concentration of biotin (i.e., deficient
and supraphysiological) might decrease the abundance of some
proteins. Notwithstanding this minor uncertainty, the highthroughput immunoblot screening used here proved to be an
excellent tool with which to identify clusters of biotin-dependent proteins. Further analysis of this data set is likely to
generate additional insights into biotin-dependent cell signaling.
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APPENDIX
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The following proteins increased by at least 25% in biotindeficient cells compared with physiological controls (SwissProt
ID): GRB2 (P29354), SAM68 (Q07666), A-RAF (P04627),
LRII/sorLA/gp250 (Q92673), c-Cbl (P22681), EB1 (Q15691),
eIF-4E (P29338), LRP (Q14764), CDC27 (P30260), PCMTI/II (P22061), stat2 (P52630), and syntaxin-4 (Q12846). The
following proteins decreased by at least 25% in biotin-deficient
cells compared with physiological controls (SwissProt ID):

AF6 (P55196), E-cadherin (P12830), EBP50 (Q14745),
GGA2 (Q9UJY4), Ku70 (P23475), b1 calcium channel
(Q02641), CDC426AP (Q07960), Gap1m (Q63713), Nogo
A (Q9JK11), Tpl-2 (Q63562), CLP-36 (Q00151), FKBP65
(Q61576), L-caldesmon (Q05682), Nurr (Q06219), RanBP3
(Q9HGZ4), TIP49G (Q9Y230), and amphiphysin (P49418).
The following proteins increased by at least 25% in cells
cultured in medium containing a pharmacological concentration of biotin compared with physiological controls (SwissProt
ID): gelsolin (P06396), CTCF (P49711), and No55 (Q92791).
The following proteins decreased by at least 25% in cells
cultured in medium containing a pharmacological concentration of biotin compared with physiological controls (SwissProt
ID): annexin II (P07355), mEPHX (P07099), TNIK
(Q9UKE5), b1-calcium channel (Q02641), ATP synthase b
(P83483), CDC42GAP (Q07960), amphiphysin (P49418),
Nogo A Q9JK11), PSD-95 (P31016), Smad4 (Q13485), Tpl-2
(Q63562), BPntase (Q9Z051), Flp-2 (Q96CV9), hSlu7
(AAD13774), ICBP90 (Q9P115), and IRS (P39570).

